7 results
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management ... ) • Takayasu's ... (GPA), Microscopic ... Polyangiitis (MPA ... Management #Treatment #ACR2021
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
(GPA) and Microscopic ... Polyangiitis (MPA ... ) - ANCA Vasculitis ... #GPA #Microscopic ... MPA #ANCA #Vasculitis
2021 ACR/VF Guidelines for Management of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

#Granulomatosis #Polyangiitis #GPA
2021 ACR/VF Guidelines ... (GPA) and Microscopic ... Polyangiitis (MPA ... #GPA #Microscopic ... MPA #ACR2021 #Management
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
(EGPA) - ANCA Vasculitis ... - ACR/VF 2021 Guidelines ... @MithuRheum #EGPA ... #ANCA #Vasculitis ... Management #Treatment #ACR2021
Vasculitis and Vasculitides - Differential Diagnosis Framework

When to Consider Vasculitis:
 • Purpura, ischemic skin lesions
 •
• Microscopic Polyangiitis ... > PR3 60% • GPA ... Vasculitis: + MPO-ANCA ... disease): • Takayasu ... (Dx: GPA, EGPA,
Vasculitis Involving the Skin - Differential Diagnosis Framework

Primary: 50% Cutaneous Vasculitis: Leukocytoclastic Vasculitis
Secondary: CTD: SLE, RA
Vasculitis Involving ... • ANCA Associated ... - Microscopic polyangiitis ... - EGPA - GPA ... arteritis • Takayasu's
Vasculitis - Differential Diagnosis Framework

When to Consider Vasculitis:
• Purpura, ischemic skin lesions
• Mononeuritis multiplex
• Hematuria, proteinuria,
GRANULOMATOUS DISEASE): Takayasu ... or as primary condition ... myeloperoxidase (MPO-ANCA ... progressive) EGPA ... > PR3 60/ GPA